Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Novel therapeutic agents for allergic disorders prepared and tested

Dec. 13, 2005

PTC-124 begins phase II study for cystic fibrosis with FDA funding

Dec. 12, 2005

R-112 disappoints in phase II comparative study in allergic rhinitis

Dec. 7, 2005

Recent GSK patent imparts novel agents for respiratory disorders

Dec. 2, 2005

Bosentan studies in pulmonary fibrosis show no effect on primary exercise endpoint

Nov. 29, 2005

Medivir and Jiangsu Hengrui Medicine Company extend COPD collaboration

Nov. 29, 2005

Recent patents report novel treatment options for respiratory disorders

Nov. 21, 2005

Altana withdraws Daxas MAA

Nov. 17, 2005

Synairgen begins phase I trial of IFN-beta to reduce asthma exacerbations

Nov. 17, 2005

European orphan drug designation for Bronchitol in cystic fibrosis

Nov. 16, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...